Back to Search
AMANDA CASHEN, MD
MD
Medical Oncology Physician
NPI: 1215953534IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
2000168794(MO)
Education
WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
Class of 1999
Research & Publications (15)
Protein losing enteropathy associated with follicular lymphoma of the small bowel.
PMID 19346818·Am J Clin Oncol·2009
5-case
Pharmacokinetics of decitabine administered as a 3-h infusion to patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
PMID 17564707·Cancer Chemother Pharmacol·2008
3-trial
Mobilizing stem cells from normal donors: is it possible to improve upon G-CSF?
PMID 17369869·Bone Marrow Transplant·2007
6-review
AMD3100: CXCR4 antagonist and rapid stem cell-mobilizing agent.
PMID 17280498·Future Oncol·2007
8-other
Cytokines and stem cell mobilization for autologous and allogeneic transplantation.
PMID 15496273·Curr Hematol Rep·2004
6-review
A phase II study of 5-day intravenous azacitidine in patients with myelodysplastic syndromes.
PMID 19650118·Am J Hematol·2009
3-trial
Allo-SCT conditioning for myelodysplastic syndrome and acute myeloid leukemia with clofarabine, cytarabine and ATG.
PMID 19139740·Bone Marrow Transplant·2009
3-trial
A phase II study of plerixafor (AMD3100) plus G-CSF for autologous hematopoietic progenitor cell mobilization in patients with Hodgkin lymphoma.
PMID 18940680·Biol Blood Marrow Transplant·2008
3-trial
Plerixafor, a CXCR4 antagonist for the mobilization of hematopoietic stem cells.
PMID 18847313·Expert Opin Biol Ther·2008
6-review
Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation.
PMID 18721768·Biol Blood Marrow Transplant·2008
8-other
Use of recombinant factor VIIa for hip surgery in a patient with factor-VII deficiency. A case report.
PMID 17272455·J Bone Joint Surg Am·2007
5-case
Second complete remission in an elderly patient with acute myeloid leukemia retreated with decitabine.
PMID 16755561·Am J Hematol·2006
8-other
Does early imatinib-induced myelosuppression predict hematologic responses in patients with advanced-phase chronic myeloid leukemia?
PMID 14615462·J Clin Oncol·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4500 FOREST PARK AVE, DIV IM BONE MARROW TRANSPLANT, 5TH, 6TH, 8TH FL
SAINT LOUIS, MO 63108 - Phone
- (314) 454-8304
Quick Facts
- NPI
- 1215953534
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 27
- Publications
- 15
Are you this provider?
Claim Your Profile